33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 30, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Acuerdo
Privacidad
FAQ
Support 24/7
Cabinet
Get premium
Donate
editar
Descargar
Export
Crear una copia
Premium
Insertar en el Sitio Web
Share
112017
Category:
Otro
Actualizado:
15 nov 2017
new approvals in solid tumors
0
0
450
Autores
Created by
Paweł Potocki
Attachments
Comments
Eventos
Imatynib
Gefitynib
Erlotynib
Sorafenib
Sunitynib Dasatynib
Lapatynib Nilotynib
Pazopanib
wemurafenib kryzotynib ruksolitynib
aflibercept aksytynib enzalutamid ewerolimus kabozantynib pertuzumab regorafenib
afatatynib dabrafenib denosumab ibrutynib trametynib trastuzumab-emtanzyna rad-223
alektynib lenwatynib kobimetynib osimertynib palbocyklib sonidegib
ceritinib niwolumab olaparyb pembrolizumab ramucyrumab
atezolizumab rukaparyb olaratumab
abemacyklib awelumab brygantynib niraparyb neratynib rybocyklib
About & Feedback
Acuerdo
Privacidad
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments